Epimedin A inhibits the PI3K/AKT/NF-κB signalling axis and osteoclast differentiation by negatively regulating TRAF6 expression

The clinician’s guide to prevention and treatment of osteoporosis

Meryl S. LeBoff, S. L. Greenspan, Karl Insogna et al. · Osteoporosis International · 2022 · 1.2K citations · Full text

Early discontinuation of treatment for osteoporosis

Anna N.A. Tosteson, Margaret R. Grove, Cristina S. Hammond et al. · The American Journal of Medicine · 2003 · 302 citations

Bone Disease, Early Discontinuation, Osteopathy +3

Opportunistic Screening Using Low-Dose CT and the Prevalence of Osteoporosis in China: A Nationwide, Multicenter Study

Xiaoguang Cheng, Kaiping Zhao, Xiaojuan Zha et al. · Journal of Bone and Mineral Research · 2020 · 223 citations · Full text

Artesunate attenuates LPS-induced osteoclastogenesis by suppressing TLR4/TRAF6 and PLCγ1-Ca2+-NFATc1 signaling pathway

Xiangzhou Zeng, Zhang Yue-yang, Qin Yang et al. · Acta Pharmacologica Sinica · 2019 · 115 citations · Full text

Inflammation, Signal Transduction, Bone Morphogenic Protein +10

Simultaneous extraction of epimedin A, B, C and icariin from Herba Epimedii by ultrasonic technique

Huafeng Zhang, Tianshun Yang, Zuozhou Li et al. · Ultrasonics Sonochemistry · 2007 · 98 citations

Medicinal Chemistry, Bioassay-guided Isolation, Epimedin A +8